Delivery Order SPE2DR25D3019-SPE2DR26FK4DE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Varivax vaccine with diluents, valued at $1,019.65 with a completion date of December 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,039.38 on November 28, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order is scheduled for completion by December 19, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,047.90 to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Varivax vaccine with diluents. The contract is a firm fixed price delivery order with an ultimate completion date of December 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Varivax vaccine with diluents. This competitively awarded, non-set-aside contract carries a ceiling value of $14,991.90 and is structured as a firm fixed-price delivery order with a completion date of December 24, 2025. The vaccines will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $1,019.69. This is a firm fixed-price delivery order issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract is not designated as a set-aside and was competitively...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,059.07 delivery order for Varivax vaccine with diluents on December 3, 2025, with an ultimate completion date of December 24, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The vaccine delivery will be performed at...
- The Defense Logistics Agency awarded a $20,642.20 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of October 16, 2025. The order will be fulfilled from the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $11,353.21. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on September 17, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Varivax vaccine with diluents, valued at $4,038.32. This firm fixed-price delivery order, with an ultimate completion date of December 22, 2025, represents a non-competitive award placed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the delivery from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $7,257.84 under a firm fixed-price contract type. The award, issued on December 3, 2025, with an ultimate completion date of December 24, 2025, represents a non-competitive, direct placement under the company's existing indefinite delivery vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as...
- SPE2DR25D3019Indefinite Delivery Contract
- SPE2DR25D3019-SPE2DR26FK4DEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Varivax vaccine with diluents, valued at $4,048.76. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of December 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, with particular emphasis on supporting military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain. This delivery order functions as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime vehicle provides comprehensive global pharmaceutical support enabling AmerisourceBergen to supply a broad range of pharmaceuticals, vaccines, and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates extensive capability in fulfilling medical procurement requirements across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 12/4/25 |